Key stats
Market capitalization
8.845MGBX
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.1GBP
About FUSION ANTIBODIES PLC ORD GBP0.04
ISIN
GB00BDQZGK16
Sector
Health Services
Industry
Medical/Nursing Services
Website
fusionantibodies.com
CEO
Adrian Kinkaid
Headquarters
Belfast
Founded
2000
Fusion Antibodies Plc engages in research, development, and manufacturing recombinant proteins and antibodies, particularly in the areas of cancer and infectious diseases. The firm also offers antibody engineering services for all stages of therapeutic and diagnostic antibody development. The company was founded by Michael Townsley and James Anthony Johnston on November 29, 2000 and is headquartered in Belfast, the United Kingdom.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0